Recent AADI News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2024 08:15:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 01:21:59 AM
- Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates • PR Newswire (US) • 08/20/2024 09:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:16:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 12:02:35 PM
- Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update • PR Newswire (US) • 08/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 10:49:05 PM
- Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update • PR Newswire (US) • 07/31/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:12:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:10:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:09:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:05:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:03:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:18:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:25:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 04:26:02 PM
- Aadi Bioscience to Participate in the Jefferies Healthcare Conference • PR Newswire (US) • 05/29/2024 08:05:00 PM
- Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting • PR Newswire (US) • 05/23/2024 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:05:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 12:07:47 PM
- Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update • PR Newswire (US) • 05/08/2024 12:00:00 PM
- Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update • PR Newswire (US) • 05/01/2024 12:01:00 PM
- Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting • PR Newswire (US) • 04/09/2024 12:00:00 PM
- Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO) • PR Newswire (US) • 03/17/2024 12:00:00 PM
- Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update • PR Newswire (US) • 03/13/2024 12:00:00 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM